忽略的决定因素和不平等的结果:超越生物医学模型重新思考与代谢功能障碍相关的脂肪性肝病
Paula Iruzubieta1, Tomás de Vega2, Javier Crespo1
1Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, Santander, Spain; Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Santander, Spain.
The lancet. Gastroenterology & hepatology
|August 30, 2025
概括
与代谢功能失调相关的脂肪性肝病 (MASLD) 影响全球30%的病例,由社会决定因素和耻辱加剧. 解决这些因素对于有效的MASLD治疗和改善患者的结果至关重要.
科学领域:
- 肝病学
- 公共卫生
- 社会医学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个普遍的全球健康问题,影响了30%的人口.
- MASLD的进展受代谢因素,健康的社会和商业决定因素以及耻辱的影响.
- 这些决定因素加剧了健康不平等,并阻碍了MASLD患者获得高质量的临床护理.
研究的目的:
- 探索社会和商业决定因素对MASLD发展和发展的影响.
- 检查耻辱作为MASLD诊断和患者生活质量障碍的作用.
- 提出一个全面的,多部门的方法来实现可持续的 MASLD 管理.
主要方法:
- 本个人观点概括了目前对MASLD的理解.
- 它整合了社会,商业和卫生系统因素的观点.
- 它提出了一个基于证据的综合管理策略.
主要成果:
- 社会和商业决定因素极大地影响了有利于MASLD的环境.
- 耻辱是一种被低估的障碍,导致诊断延迟,生活质量下降.
- 可持续的 MASLD 管理需要采用综合性的多部门方法.
结论:
- 除了代谢因素之外,MASLD还需要解决健康的社会和商业决定因素.
- 减轻耻辱感对于改善患者的结果和减少诊断延迟至关重要.
- 提出一个全面的多部门战略,以实现有效和可持续的MASLD管理.
相关概念视频
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
79
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
79
Liver Physiology
1.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.1K
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54


